# J2HBiotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/j2hbiotech

- Industry: Biotechnology
- Headquarters: Suwon, South Korea
- Website: www.j2hbio.com
- Total disclosed funding: $25M
- Latest round: Series C (Jun 30, 2020)
- Investors on record: 14

## About

Founded in 2014 and based in Suwon, South Korea, J2HBiotech is a biopharmaceutical company that focuses on the research and development of Non-Alcoholic Steatohepatitis (NASH) pharmaceuticals. In 2017, the company won a patent lawsuit for a new hepatitis B improvement drug. In 2018, the company established its third factory. In 2019, the company was selected as a preliminary unicorn company.

The company's main products include drugs J2H-1701, J2H-1801, J2H-1908 and J2H-PROTAC, etc. The company's products are used in diseases such as amyotrophic lateral sclerosis, liver fibrosis, multiple sclerosis and tumors.

## Funding rounds

- Series C, Jun 30, 2020, $11M — Korea Investment & Securities, AJU IB Investment, WOORI Venture Partners, Mirae Asset Venture Investment, Renaissance Asset Management
- Series B, Sep 13, 2018, $12M — AJU IB Investment, WOORI Venture Partners, Shinhan Securities, Partners Investment, Kolon Investment, BNH Investment, Blue Corner, Samsung Securities, LSK Investment, AhnGook Pharm
- Series A, Dec 26, 2016, $2.5M — Korea Technology Finance Corporation, BNH Investment, LSK Investment

## Investors

- Korea Technology Finance Corporation — Series A
- BNH Investment (https://capitalatlas.ai/funds/bnh-investment) — Series A, Series B
- LSK Investment (https://capitalatlas.ai/funds/lsk-investment) — Series A, Series B
- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series B, Series C
- WOORI Venture Partners (https://capitalatlas.ai/funds/woori-venture-partners) — Series B, Series C
- Shinhan Securities (https://capitalatlas.ai/funds/shinhan-securities) — Series B
- Partners Investment (https://capitalatlas.ai/funds/partners-investment) — Series B
- Kolon Investment (https://capitalatlas.ai/funds/kolon-investment) — Series B
- Blue Corner — Series B
- Samsung Securities — Series B
- AhnGook Pharm — Series B
- Korea Investment & Securities (https://capitalatlas.ai/funds/korea-investment-securities) — Series C
- Mirae Asset Venture Investment (https://capitalatlas.ai/funds/mirae-asset-venture-investment) — Series C
- Renaissance Asset Management — Series C